Nicorandil is a hybrid ATP-sensitive K+ (KATP) channel opener and nicotinamide nitrate NO donor. Selectively activates SUR2B- versus SUR2A-containing KATP channels. It enhances endothelial NO synthase expression and protects against ischemic ventricular arrhythmias. It attenuates MMP-2 and -9 plasma levels, thereby suppressing ventricular remodeling. A clinically useful antianginal agent.
Product Specification
| MW: | 211.2 |
| |
| CAS: | 65141-46-0 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Shipping: | Shipped on Blue Ice |
| |
| Long Term Storage: | -20°C |
| |
Please mouse over
Product Literature References
Small molecule activation of apurinic/apyrimidinic endonuclease 1 reduces DNA damage induced by cisplatin in cultured sensory neurons: M.M. Georgiadis, et al.; DNA Repair (Amst.)
41, 32 (2016),
Application(s): Cell culture,
Abstract;
Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction: T. Fujiwara, et al.; Heart Vessels
22, 303 (2007),
Abstract;
Nicorandil improves post-ischemic myocardial dysfunction in association with opening the mitochondrial K(ATP) channels and decreasing hydroxyl radicals in isolated rat hearts: C. Lu, et al.; Circ. J.
70, 1650 (2006),
Abstract;
Nicorandil protects against lethal ischemic ventricular arrhythmias and up-regulates endothelial nitric oxide synthase expression and sulfonylurea receptor 2 mRNA in conscious rats with acute myocardial infarction: S. Horinaka, et. al.; Cardiovasc. Drugs Ther.
18, 13 (2004),
Abstract;
SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil: T. Shindo, et al.; Br. J. Pharmacol.
124, 985 (1998),
Abstract;
